Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019637
Filing Date
2023-05-09
Accepted
2023-05-09 16:07:46
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q drrx-20230331.htm   iXBRL 10-Q 1573544
2 EX-31.1 drrx-ex31_1.htm EX-31 13938
3 EX-31.2 drrx-ex31_2.htm EX-31 13468
4 EX-32.1 drrx-ex32_1.htm EX-32 6999
5 EX-32.2 drrx-ex32_2.htm EX-32 7573
  Complete submission text file 0000950170-23-019637.txt   6907191

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drrx-20230331_pre.xml EX-101.PRE 258835
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drrx-20230331_lab.xml EX-101.LAB 362571
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drrx-20230331_cal.xml EX-101.CAL 52804
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drrx-20230331.xsd EX-101.SCH 41736
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drrx-20230331_def.xml EX-101.DEF 148413
50 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20230331_htm.xml XML 1447743
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 23901987
SIC: 2834 Pharmaceutical Preparations